MedTrace Logo

Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

NCT03007706 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-01-04

No results posted yet for this study

Summary

This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.

Conditions

  • Postpartum Infectious Morbidity in Cesarean Section Delivery

Interventions

PROCEDURE

Women undergo cesarean section delivery

Sponsors & Collaborators

  • Raghda Gamal Mohamed

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007706 on ClinicalTrials.gov